Global HIV Diagnostics Market Research Report 2026(Status and Outlook)
The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global HIV Diagnostics market size was estimated at USD 3099.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global HIV Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global HIV Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the HIV Diagnostics market.
Global HIV Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Beckman Coulter
Partec
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
Qiagen
BioMerieux
Market Segmentation (by Type)
Consumables
Assay, Kits and Reagents
Other Consumables
Instruments
Software and Services
Market Segmentation (by Application)
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the HIV Diagnostics Market
Overview of the regional outlook of the HIV Diagnostics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the HIV Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of HIV Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global HIV Diagnostics market size was estimated at USD 3099.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global HIV Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global HIV Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the HIV Diagnostics market.
Global HIV Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Beckman Coulter
Partec
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
Qiagen
BioMerieux
Market Segmentation (by Type)
Consumables
Assay, Kits and Reagents
Other Consumables
Instruments
Software and Services
Market Segmentation (by Application)
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the HIV Diagnostics Market
Overview of the regional outlook of the HIV Diagnostics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the HIV Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of HIV Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of HIV Diagnostics
1.2 Key Market Segments
1.2.1 HIV Diagnostics Segment by Type
1.2.2 HIV Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HIV DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global HIV Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global HIV Diagnostics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HIV DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global HIV Diagnostics Product Life Cycle
3.3 Global HIV Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global HIV Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global HIV Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 HIV Diagnostics Market Competitive Situation and Trends
3.8.1 HIV Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest HIV Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HIV DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 HIV Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HIV DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global HIV Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to HIV Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 HIV DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global HIV Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global HIV Diagnostics Market Size by Type (2020-2025)
6.4 Global HIV Diagnostics Price by Type (2020-2025)
7 HIV DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global HIV Diagnostics Market Sales by Application (2020-2025)
7.3 Global HIV Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global HIV Diagnostics Sales Growth Rate by Application (2020-2025)
8 HIV DIAGNOSTICS MARKET SALES BY REGION
8.1 Global HIV Diagnostics Sales by Region
8.1.1 Global HIV Diagnostics Sales by Region
8.1.2 Global HIV Diagnostics Sales Market Share by Region
8.2 Global HIV Diagnostics Market Size by Region
8.2.1 Global HIV Diagnostics Market Size by Region
8.2.2 Global HIV Diagnostics Market Size by Region
8.3 North America
8.3.1 North America HIV Diagnostics Sales by Country
8.3.2 North America HIV Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe HIV Diagnostics Sales by Country
8.4.2 Europe HIV Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific HIV Diagnostics Sales by Region
8.5.2 Asia Pacific HIV Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America HIV Diagnostics Sales by Country
8.6.2 South America HIV Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa HIV Diagnostics Sales by Region
8.7.2 Middle East and Africa HIV Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HIV DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of HIV Diagnostics by Region(2020-2025)
9.2 Global HIV Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global HIV Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America HIV Diagnostics Production
9.4.1 North America HIV Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America HIV Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe HIV Diagnostics Production
9.5.1 Europe HIV Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe HIV Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan HIV Diagnostics Production (2020-2025)
9.6.1 Japan HIV Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan HIV Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China HIV Diagnostics Production (2020-2025)
9.7.1 China HIV Diagnostics Production Growth Rate (2020-2025)
9.7.2 China HIV Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott HIV Diagnostics Product Overview
10.1.3 Abbott HIV Diagnostics Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 Abbott Healthcare
10.2.1 Abbott Healthcare Basic Information
10.2.2 Abbott Healthcare HIV Diagnostics Product Overview
10.2.3 Abbott Healthcare HIV Diagnostics Product Market Performance
10.2.4 Abbott Healthcare Business Overview
10.2.5 Abbott Healthcare SWOT Analysis
10.2.6 Abbott Healthcare Recent Developments
10.3 Abbvie Inc.
10.3.1 Abbvie Inc. Basic Information
10.3.2 Abbvie Inc. HIV Diagnostics Product Overview
10.3.3 Abbvie Inc. HIV Diagnostics Product Market Performance
10.3.4 Abbvie Inc. Business Overview
10.3.5 Abbvie Inc. SWOT Analysis
10.3.6 Abbvie Inc. Recent Developments
10.4 Brsitol-Myers Squibb
10.4.1 Brsitol-Myers Squibb Basic Information
10.4.2 Brsitol-Myers Squibb HIV Diagnostics Product Overview
10.4.3 Brsitol-Myers Squibb HIV Diagnostics Product Market Performance
10.4.4 Brsitol-Myers Squibb Business Overview
10.4.5 Brsitol-Myers Squibb Recent Developments
10.5 Janssen Therapeutics
10.5.1 Janssen Therapeutics Basic Information
10.5.2 Janssen Therapeutics HIV Diagnostics Product Overview
10.5.3 Janssen Therapeutics HIV Diagnostics Product Market Performance
10.5.4 Janssen Therapeutics Business Overview
10.5.5 Janssen Therapeutics Recent Developments
10.6 Gilead Sciences
10.6.1 Gilead Sciences Basic Information
10.6.2 Gilead Sciences HIV Diagnostics Product Overview
10.6.3 Gilead Sciences HIV Diagnostics Product Market Performance
10.6.4 Gilead Sciences Business Overview
10.6.5 Gilead Sciences Recent Developments
10.7 Merck and Co. Inc
10.7.1 Merck and Co. Inc Basic Information
10.7.2 Merck and Co. Inc HIV Diagnostics Product Overview
10.7.3 Merck and Co. Inc HIV Diagnostics Product Market Performance
10.7.4 Merck and Co. Inc Business Overview
10.7.5 Merck and Co. Inc Recent Developments
10.8 VIIV Healthcare
10.8.1 VIIV Healthcare Basic Information
10.8.2 VIIV Healthcare HIV Diagnostics Product Overview
10.8.3 VIIV Healthcare HIV Diagnostics Product Market Performance
10.8.4 VIIV Healthcare Business Overview
10.8.5 VIIV Healthcare Recent Developments
10.9 BD Biosciences
10.9.1 BD Biosciences Basic Information
10.9.2 BD Biosciences HIV Diagnostics Product Overview
10.9.3 BD Biosciences HIV Diagnostics Product Market Performance
10.9.4 BD Biosciences Business Overview
10.9.5 BD Biosciences Recent Developments
10.10 Beckman Coulter
10.10.1 Beckman Coulter Basic Information
10.10.2 Beckman Coulter HIV Diagnostics Product Overview
10.10.3 Beckman Coulter HIV Diagnostics Product Market Performance
10.10.4 Beckman Coulter Business Overview
10.10.5 Beckman Coulter Recent Developments
10.11 Partec
10.11.1 Partec Basic Information
10.11.2 Partec HIV Diagnostics Product Overview
10.11.3 Partec HIV Diagnostics Product Market Performance
10.11.4 Partec Business Overview
10.11.5 Partec Recent Developments
10.12 Sysmex
10.12.1 Sysmex Basic Information
10.12.2 Sysmex HIV Diagnostics Product Overview
10.12.3 Sysmex HIV Diagnostics Product Market Performance
10.12.4 Sysmex Business Overview
10.12.5 Sysmex Recent Developments
10.13 Apogee Flow Systems
10.13.1 Apogee Flow Systems Basic Information
10.13.2 Apogee Flow Systems HIV Diagnostics Product Overview
10.13.3 Apogee Flow Systems HIV Diagnostics Product Market Performance
10.13.4 Apogee Flow Systems Business Overview
10.13.5 Apogee Flow Systems Recent Developments
10.14 PointCare Technologies Inc.
10.14.1 PointCare Technologies Inc. Basic Information
10.14.2 PointCare Technologies Inc. HIV Diagnostics Product Overview
10.14.3 PointCare Technologies Inc. HIV Diagnostics Product Market Performance
10.14.4 PointCare Technologies Inc. Business Overview
10.14.5 PointCare Technologies Inc. Recent Developments
10.15 Zyomyx Inc.
10.15.1 Zyomyx Inc. Basic Information
10.15.2 Zyomyx Inc. HIV Diagnostics Product Overview
10.15.3 Zyomyx Inc. HIV Diagnostics Product Market Performance
10.15.4 Zyomyx Inc. Business Overview
10.15.5 Zyomyx Inc. Recent Developments
10.16 Mylan inc.
10.16.1 Mylan inc. Basic Information
10.16.2 Mylan inc. HIV Diagnostics Product Overview
10.16.3 Mylan inc. HIV Diagnostics Product Market Performance
10.16.4 Mylan inc. Business Overview
10.16.5 Mylan inc. Recent Developments
10.17 Roche Diagnostics
10.17.1 Roche Diagnostics Basic Information
10.17.2 Roche Diagnostics HIV Diagnostics Product Overview
10.17.3 Roche Diagnostics HIV Diagnostics Product Market Performance
10.17.4 Roche Diagnostics Business Overview
10.17.5 Roche Diagnostics Recent Developments
10.18 Siemens Healthcare
10.18.1 Siemens Healthcare Basic Information
10.18.2 Siemens Healthcare HIV Diagnostics Product Overview
10.18.3 Siemens Healthcare HIV Diagnostics Product Market Performance
10.18.4 Siemens Healthcare Business Overview
10.18.5 Siemens Healthcare Recent Developments
10.19 Qiagen
10.19.1 Qiagen Basic Information
10.19.2 Qiagen HIV Diagnostics Product Overview
10.19.3 Qiagen HIV Diagnostics Product Market Performance
10.19.4 Qiagen Business Overview
10.19.5 Qiagen Recent Developments
10.20 BioMerieux
10.20.1 BioMerieux Basic Information
10.20.2 BioMerieux HIV Diagnostics Product Overview
10.20.3 BioMerieux HIV Diagnostics Product Market Performance
10.20.4 BioMerieux Business Overview
10.20.5 BioMerieux Recent Developments
11 HIV DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global HIV Diagnostics Market Size Forecast
11.2 Global HIV Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe HIV Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific HIV Diagnostics Market Size Forecast by Region
11.2.4 South America HIV Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of HIV Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global HIV Diagnostics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of HIV Diagnostics by Type (2026-2035)
12.1.2 Global HIV Diagnostics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of HIV Diagnostics by Type (2026-2035)
12.2 Global HIV Diagnostics Market Forecast by Application (2026-2035)
12.2.1 Global HIV Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global HIV Diagnostics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of HIV Diagnostics
1.2 Key Market Segments
1.2.1 HIV Diagnostics Segment by Type
1.2.2 HIV Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HIV DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global HIV Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global HIV Diagnostics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HIV DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global HIV Diagnostics Product Life Cycle
3.3 Global HIV Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global HIV Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global HIV Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 HIV Diagnostics Market Competitive Situation and Trends
3.8.1 HIV Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest HIV Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HIV DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 HIV Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HIV DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global HIV Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to HIV Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 HIV DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global HIV Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global HIV Diagnostics Market Size by Type (2020-2025)
6.4 Global HIV Diagnostics Price by Type (2020-2025)
7 HIV DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global HIV Diagnostics Market Sales by Application (2020-2025)
7.3 Global HIV Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global HIV Diagnostics Sales Growth Rate by Application (2020-2025)
8 HIV DIAGNOSTICS MARKET SALES BY REGION
8.1 Global HIV Diagnostics Sales by Region
8.1.1 Global HIV Diagnostics Sales by Region
8.1.2 Global HIV Diagnostics Sales Market Share by Region
8.2 Global HIV Diagnostics Market Size by Region
8.2.1 Global HIV Diagnostics Market Size by Region
8.2.2 Global HIV Diagnostics Market Size by Region
8.3 North America
8.3.1 North America HIV Diagnostics Sales by Country
8.3.2 North America HIV Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe HIV Diagnostics Sales by Country
8.4.2 Europe HIV Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific HIV Diagnostics Sales by Region
8.5.2 Asia Pacific HIV Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America HIV Diagnostics Sales by Country
8.6.2 South America HIV Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa HIV Diagnostics Sales by Region
8.7.2 Middle East and Africa HIV Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HIV DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of HIV Diagnostics by Region(2020-2025)
9.2 Global HIV Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global HIV Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America HIV Diagnostics Production
9.4.1 North America HIV Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America HIV Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe HIV Diagnostics Production
9.5.1 Europe HIV Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe HIV Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan HIV Diagnostics Production (2020-2025)
9.6.1 Japan HIV Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan HIV Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China HIV Diagnostics Production (2020-2025)
9.7.1 China HIV Diagnostics Production Growth Rate (2020-2025)
9.7.2 China HIV Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott HIV Diagnostics Product Overview
10.1.3 Abbott HIV Diagnostics Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 Abbott Healthcare
10.2.1 Abbott Healthcare Basic Information
10.2.2 Abbott Healthcare HIV Diagnostics Product Overview
10.2.3 Abbott Healthcare HIV Diagnostics Product Market Performance
10.2.4 Abbott Healthcare Business Overview
10.2.5 Abbott Healthcare SWOT Analysis
10.2.6 Abbott Healthcare Recent Developments
10.3 Abbvie Inc.
10.3.1 Abbvie Inc. Basic Information
10.3.2 Abbvie Inc. HIV Diagnostics Product Overview
10.3.3 Abbvie Inc. HIV Diagnostics Product Market Performance
10.3.4 Abbvie Inc. Business Overview
10.3.5 Abbvie Inc. SWOT Analysis
10.3.6 Abbvie Inc. Recent Developments
10.4 Brsitol-Myers Squibb
10.4.1 Brsitol-Myers Squibb Basic Information
10.4.2 Brsitol-Myers Squibb HIV Diagnostics Product Overview
10.4.3 Brsitol-Myers Squibb HIV Diagnostics Product Market Performance
10.4.4 Brsitol-Myers Squibb Business Overview
10.4.5 Brsitol-Myers Squibb Recent Developments
10.5 Janssen Therapeutics
10.5.1 Janssen Therapeutics Basic Information
10.5.2 Janssen Therapeutics HIV Diagnostics Product Overview
10.5.3 Janssen Therapeutics HIV Diagnostics Product Market Performance
10.5.4 Janssen Therapeutics Business Overview
10.5.5 Janssen Therapeutics Recent Developments
10.6 Gilead Sciences
10.6.1 Gilead Sciences Basic Information
10.6.2 Gilead Sciences HIV Diagnostics Product Overview
10.6.3 Gilead Sciences HIV Diagnostics Product Market Performance
10.6.4 Gilead Sciences Business Overview
10.6.5 Gilead Sciences Recent Developments
10.7 Merck and Co. Inc
10.7.1 Merck and Co. Inc Basic Information
10.7.2 Merck and Co. Inc HIV Diagnostics Product Overview
10.7.3 Merck and Co. Inc HIV Diagnostics Product Market Performance
10.7.4 Merck and Co. Inc Business Overview
10.7.5 Merck and Co. Inc Recent Developments
10.8 VIIV Healthcare
10.8.1 VIIV Healthcare Basic Information
10.8.2 VIIV Healthcare HIV Diagnostics Product Overview
10.8.3 VIIV Healthcare HIV Diagnostics Product Market Performance
10.8.4 VIIV Healthcare Business Overview
10.8.5 VIIV Healthcare Recent Developments
10.9 BD Biosciences
10.9.1 BD Biosciences Basic Information
10.9.2 BD Biosciences HIV Diagnostics Product Overview
10.9.3 BD Biosciences HIV Diagnostics Product Market Performance
10.9.4 BD Biosciences Business Overview
10.9.5 BD Biosciences Recent Developments
10.10 Beckman Coulter
10.10.1 Beckman Coulter Basic Information
10.10.2 Beckman Coulter HIV Diagnostics Product Overview
10.10.3 Beckman Coulter HIV Diagnostics Product Market Performance
10.10.4 Beckman Coulter Business Overview
10.10.5 Beckman Coulter Recent Developments
10.11 Partec
10.11.1 Partec Basic Information
10.11.2 Partec HIV Diagnostics Product Overview
10.11.3 Partec HIV Diagnostics Product Market Performance
10.11.4 Partec Business Overview
10.11.5 Partec Recent Developments
10.12 Sysmex
10.12.1 Sysmex Basic Information
10.12.2 Sysmex HIV Diagnostics Product Overview
10.12.3 Sysmex HIV Diagnostics Product Market Performance
10.12.4 Sysmex Business Overview
10.12.5 Sysmex Recent Developments
10.13 Apogee Flow Systems
10.13.1 Apogee Flow Systems Basic Information
10.13.2 Apogee Flow Systems HIV Diagnostics Product Overview
10.13.3 Apogee Flow Systems HIV Diagnostics Product Market Performance
10.13.4 Apogee Flow Systems Business Overview
10.13.5 Apogee Flow Systems Recent Developments
10.14 PointCare Technologies Inc.
10.14.1 PointCare Technologies Inc. Basic Information
10.14.2 PointCare Technologies Inc. HIV Diagnostics Product Overview
10.14.3 PointCare Technologies Inc. HIV Diagnostics Product Market Performance
10.14.4 PointCare Technologies Inc. Business Overview
10.14.5 PointCare Technologies Inc. Recent Developments
10.15 Zyomyx Inc.
10.15.1 Zyomyx Inc. Basic Information
10.15.2 Zyomyx Inc. HIV Diagnostics Product Overview
10.15.3 Zyomyx Inc. HIV Diagnostics Product Market Performance
10.15.4 Zyomyx Inc. Business Overview
10.15.5 Zyomyx Inc. Recent Developments
10.16 Mylan inc.
10.16.1 Mylan inc. Basic Information
10.16.2 Mylan inc. HIV Diagnostics Product Overview
10.16.3 Mylan inc. HIV Diagnostics Product Market Performance
10.16.4 Mylan inc. Business Overview
10.16.5 Mylan inc. Recent Developments
10.17 Roche Diagnostics
10.17.1 Roche Diagnostics Basic Information
10.17.2 Roche Diagnostics HIV Diagnostics Product Overview
10.17.3 Roche Diagnostics HIV Diagnostics Product Market Performance
10.17.4 Roche Diagnostics Business Overview
10.17.5 Roche Diagnostics Recent Developments
10.18 Siemens Healthcare
10.18.1 Siemens Healthcare Basic Information
10.18.2 Siemens Healthcare HIV Diagnostics Product Overview
10.18.3 Siemens Healthcare HIV Diagnostics Product Market Performance
10.18.4 Siemens Healthcare Business Overview
10.18.5 Siemens Healthcare Recent Developments
10.19 Qiagen
10.19.1 Qiagen Basic Information
10.19.2 Qiagen HIV Diagnostics Product Overview
10.19.3 Qiagen HIV Diagnostics Product Market Performance
10.19.4 Qiagen Business Overview
10.19.5 Qiagen Recent Developments
10.20 BioMerieux
10.20.1 BioMerieux Basic Information
10.20.2 BioMerieux HIV Diagnostics Product Overview
10.20.3 BioMerieux HIV Diagnostics Product Market Performance
10.20.4 BioMerieux Business Overview
10.20.5 BioMerieux Recent Developments
11 HIV DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global HIV Diagnostics Market Size Forecast
11.2 Global HIV Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe HIV Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific HIV Diagnostics Market Size Forecast by Region
11.2.4 South America HIV Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of HIV Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global HIV Diagnostics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of HIV Diagnostics by Type (2026-2035)
12.1.2 Global HIV Diagnostics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of HIV Diagnostics by Type (2026-2035)
12.2 Global HIV Diagnostics Market Forecast by Application (2026-2035)
12.2.1 Global HIV Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global HIV Diagnostics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global HIV Diagnostics Market Size by Type (M USD)
Table 4. Global HIV Diagnostics Market Size by Application
Table 5. HIV Diagnostics Market Size Comparison by Region (M USD)
Table 6. Global HIV Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global HIV Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global HIV Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global HIV Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Diagnostics as of 2025)
Table 11. Global Market HIV Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global HIV Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. HIV Diagnostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global HIV Diagnostics Sales by Type (K Units)
Table 27. Global HIV Diagnostics Market Size by Type (M USD)
Table 28. Global HIV Diagnostics Sales (K Units) by Type (2020-2025)
Table 29. Global HIV Diagnostics Sales Market Share by Type (2020-2025)
Table 30. Global HIV Diagnostics Market Size (M USD) by Type (2020-2025)
Table 31. Global HIV Diagnostics Market Share by Type (2020-2025)
Table 32. Global HIV Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 33. Global HIV Diagnostics Sales (K Units) by Application
Table 34. Global HIV Diagnostics Market Size by Application
Table 35. Global HIV Diagnostics Sales by Application (2020-2025) & (K Units)
Table 36. Global HIV Diagnostics Sales Market Share by Application (2020-2025)
Table 37. Global HIV Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 38. Global HIV Diagnostics Market Share by Application (2020-2025)
Table 39. Global HIV Diagnostics Sales Growth Rate by Application (2020-2025)
Table 40. Global HIV Diagnostics Sales by Region (2020-2025) & (K Units)
Table 41. Global HIV Diagnostics Sales Market Share by Region (2020-2025)
Table 42. Global HIV Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 43. Global HIV Diagnostics Market Size by Region (2020-2025)
Table 44. North America HIV Diagnostics Sales by Country (2020-2025) & (K Units)
Table 45. North America HIV Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe HIV Diagnostics Sales by Country (2020-2025) & (K Units)
Table 47. Europe HIV Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific HIV Diagnostics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific HIV Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 50. South America HIV Diagnostics Sales by Country (2020-2025) & (K Units)
Table 51. South America HIV Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa HIV Diagnostics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa HIV Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 54. Global HIV Diagnostics Production (K Units) by Region(2020-2025)
Table 55. Global HIV Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global HIV Diagnostics Revenue Market Share by Region (2020-2025)
Table 57. Global HIV Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America HIV Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe HIV Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan HIV Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China HIV Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Basic Information
Table 63. Abbott HIV Diagnostics Product Overview
Table 64. Abbott HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Business Overview
Table 66. Abbott SWOT Analysis
Table 67. Abbott Recent Developments
Table 68. Abbott Healthcare Basic Information
Table 69. Abbott Healthcare HIV Diagnostics Product Overview
Table 70. Abbott Healthcare HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Abbott Healthcare Business Overview
Table 72. Abbott Healthcare SWOT Analysis
Table 73. Abbott Healthcare Recent Developments
Table 74. Abbvie Inc. Basic Information
Table 75. Abbvie Inc. HIV Diagnostics Product Overview
Table 76. Abbvie Inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbvie Inc. Business Overview
Table 78. Abbvie Inc. SWOT Analysis
Table 79. Abbvie Inc. Recent Developments
Table 80. Brsitol-Myers Squibb Basic Information
Table 81. Brsitol-Myers Squibb HIV Diagnostics Product Overview
Table 82. Brsitol-Myers Squibb HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Brsitol-Myers Squibb Business Overview
Table 84. Brsitol-Myers Squibb Recent Developments
Table 85. Janssen Therapeutics Basic Information
Table 86. Janssen Therapeutics HIV Diagnostics Product Overview
Table 87. Janssen Therapeutics HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Janssen Therapeutics Business Overview
Table 89. Janssen Therapeutics Recent Developments
Table 90. Gilead Sciences Basic Information
Table 91. Gilead Sciences HIV Diagnostics Product Overview
Table 92. Gilead Sciences HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Gilead Sciences Business Overview
Table 94. Gilead Sciences Recent Developments
Table 95. Merck and Co. Inc Basic Information
Table 96. Merck and Co. Inc HIV Diagnostics Product Overview
Table 97. Merck and Co. Inc HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Merck and Co. Inc Business Overview
Table 99. Merck and Co. Inc Recent Developments
Table 100. VIIV Healthcare Basic Information
Table 101. VIIV Healthcare HIV Diagnostics Product Overview
Table 102. VIIV Healthcare HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. VIIV Healthcare Business Overview
Table 104. VIIV Healthcare Recent Developments
Table 105. BD Biosciences Basic Information
Table 106. BD Biosciences HIV Diagnostics Product Overview
Table 107. BD Biosciences HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. BD Biosciences Business Overview
Table 109. BD Biosciences Recent Developments
Table 110. Beckman Coulter Basic Information
Table 111. Beckman Coulter HIV Diagnostics Product Overview
Table 112. Beckman Coulter HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Beckman Coulter Business Overview
Table 114. Beckman Coulter Recent Developments
Table 115. Partec Basic Information
Table 116. Partec HIV Diagnostics Product Overview
Table 117. Partec HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Partec Business Overview
Table 119. Partec Recent Developments
Table 120. Sysmex Basic Information
Table 121. Sysmex HIV Diagnostics Product Overview
Table 122. Sysmex HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Sysmex Business Overview
Table 124. Sysmex Recent Developments
Table 125. Apogee Flow Systems Basic Information
Table 126. Apogee Flow Systems HIV Diagnostics Product Overview
Table 127. Apogee Flow Systems HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Apogee Flow Systems Business Overview
Table 129. Apogee Flow Systems Recent Developments
Table 130. PointCare Technologies Inc. Basic Information
Table 131. PointCare Technologies Inc. HIV Diagnostics Product Overview
Table 132. PointCare Technologies Inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. PointCare Technologies Inc. Business Overview
Table 134. PointCare Technologies Inc. Recent Developments
Table 135. Zyomyx Inc. Basic Information
Table 136. Zyomyx Inc. HIV Diagnostics Product Overview
Table 137. Zyomyx Inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Zyomyx Inc. Business Overview
Table 139. Zyomyx Inc. Recent Developments
Table 140. Mylan inc. Basic Information
Table 141. Mylan inc. HIV Diagnostics Product Overview
Table 142. Mylan inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Mylan inc. Business Overview
Table 144. Mylan inc. Recent Developments
Table 145. Roche Diagnostics Basic Information
Table 146. Roche Diagnostics HIV Diagnostics Product Overview
Table 147. Roche Diagnostics HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Roche Diagnostics Business Overview
Table 149. Roche Diagnostics Recent Developments
Table 150. Siemens Healthcare Basic Information
Table 151. Siemens Healthcare HIV Diagnostics Product Overview
Table 152. Siemens Healthcare HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Siemens Healthcare Business Overview
Table 154. Siemens Healthcare Recent Developments
Table 155. Qiagen Basic Information
Table 156. Qiagen HIV Diagnostics Product Overview
Table 157. Qiagen HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Qiagen Business Overview
Table 159. Qiagen Recent Developments
Table 160. BioMerieux Basic Information
Table 161. BioMerieux HIV Diagnostics Product Overview
Table 162. BioMerieux HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. BioMerieux Business Overview
Table 164. BioMerieux Recent Developments
Table 165. Global HIV Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 166. Global HIV Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America HIV Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 168. North America HIV Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe HIV Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 170. Europe HIV Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific HIV Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 172. Asia Pacific HIV Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America HIV Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 174. South America HIV Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa HIV Diagnostics Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa HIV Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global HIV Diagnostics Sales Forecast by Type (2026-2035) & (K Units)
Table 178. Global HIV Diagnostics Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global HIV Diagnostics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 180. Global HIV Diagnostics Sales (K Units) Forecast by Application (2026-2035)
Table 181. Global HIV Diagnostics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global HIV Diagnostics Market Size by Type (M USD)
Table 4. Global HIV Diagnostics Market Size by Application
Table 5. HIV Diagnostics Market Size Comparison by Region (M USD)
Table 6. Global HIV Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global HIV Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global HIV Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global HIV Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Diagnostics as of 2025)
Table 11. Global Market HIV Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global HIV Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. HIV Diagnostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global HIV Diagnostics Sales by Type (K Units)
Table 27. Global HIV Diagnostics Market Size by Type (M USD)
Table 28. Global HIV Diagnostics Sales (K Units) by Type (2020-2025)
Table 29. Global HIV Diagnostics Sales Market Share by Type (2020-2025)
Table 30. Global HIV Diagnostics Market Size (M USD) by Type (2020-2025)
Table 31. Global HIV Diagnostics Market Share by Type (2020-2025)
Table 32. Global HIV Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 33. Global HIV Diagnostics Sales (K Units) by Application
Table 34. Global HIV Diagnostics Market Size by Application
Table 35. Global HIV Diagnostics Sales by Application (2020-2025) & (K Units)
Table 36. Global HIV Diagnostics Sales Market Share by Application (2020-2025)
Table 37. Global HIV Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 38. Global HIV Diagnostics Market Share by Application (2020-2025)
Table 39. Global HIV Diagnostics Sales Growth Rate by Application (2020-2025)
Table 40. Global HIV Diagnostics Sales by Region (2020-2025) & (K Units)
Table 41. Global HIV Diagnostics Sales Market Share by Region (2020-2025)
Table 42. Global HIV Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 43. Global HIV Diagnostics Market Size by Region (2020-2025)
Table 44. North America HIV Diagnostics Sales by Country (2020-2025) & (K Units)
Table 45. North America HIV Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe HIV Diagnostics Sales by Country (2020-2025) & (K Units)
Table 47. Europe HIV Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific HIV Diagnostics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific HIV Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 50. South America HIV Diagnostics Sales by Country (2020-2025) & (K Units)
Table 51. South America HIV Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa HIV Diagnostics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa HIV Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 54. Global HIV Diagnostics Production (K Units) by Region(2020-2025)
Table 55. Global HIV Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global HIV Diagnostics Revenue Market Share by Region (2020-2025)
Table 57. Global HIV Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America HIV Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe HIV Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan HIV Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China HIV Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Basic Information
Table 63. Abbott HIV Diagnostics Product Overview
Table 64. Abbott HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Business Overview
Table 66. Abbott SWOT Analysis
Table 67. Abbott Recent Developments
Table 68. Abbott Healthcare Basic Information
Table 69. Abbott Healthcare HIV Diagnostics Product Overview
Table 70. Abbott Healthcare HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Abbott Healthcare Business Overview
Table 72. Abbott Healthcare SWOT Analysis
Table 73. Abbott Healthcare Recent Developments
Table 74. Abbvie Inc. Basic Information
Table 75. Abbvie Inc. HIV Diagnostics Product Overview
Table 76. Abbvie Inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbvie Inc. Business Overview
Table 78. Abbvie Inc. SWOT Analysis
Table 79. Abbvie Inc. Recent Developments
Table 80. Brsitol-Myers Squibb Basic Information
Table 81. Brsitol-Myers Squibb HIV Diagnostics Product Overview
Table 82. Brsitol-Myers Squibb HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Brsitol-Myers Squibb Business Overview
Table 84. Brsitol-Myers Squibb Recent Developments
Table 85. Janssen Therapeutics Basic Information
Table 86. Janssen Therapeutics HIV Diagnostics Product Overview
Table 87. Janssen Therapeutics HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Janssen Therapeutics Business Overview
Table 89. Janssen Therapeutics Recent Developments
Table 90. Gilead Sciences Basic Information
Table 91. Gilead Sciences HIV Diagnostics Product Overview
Table 92. Gilead Sciences HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Gilead Sciences Business Overview
Table 94. Gilead Sciences Recent Developments
Table 95. Merck and Co. Inc Basic Information
Table 96. Merck and Co. Inc HIV Diagnostics Product Overview
Table 97. Merck and Co. Inc HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Merck and Co. Inc Business Overview
Table 99. Merck and Co. Inc Recent Developments
Table 100. VIIV Healthcare Basic Information
Table 101. VIIV Healthcare HIV Diagnostics Product Overview
Table 102. VIIV Healthcare HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. VIIV Healthcare Business Overview
Table 104. VIIV Healthcare Recent Developments
Table 105. BD Biosciences Basic Information
Table 106. BD Biosciences HIV Diagnostics Product Overview
Table 107. BD Biosciences HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. BD Biosciences Business Overview
Table 109. BD Biosciences Recent Developments
Table 110. Beckman Coulter Basic Information
Table 111. Beckman Coulter HIV Diagnostics Product Overview
Table 112. Beckman Coulter HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Beckman Coulter Business Overview
Table 114. Beckman Coulter Recent Developments
Table 115. Partec Basic Information
Table 116. Partec HIV Diagnostics Product Overview
Table 117. Partec HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Partec Business Overview
Table 119. Partec Recent Developments
Table 120. Sysmex Basic Information
Table 121. Sysmex HIV Diagnostics Product Overview
Table 122. Sysmex HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Sysmex Business Overview
Table 124. Sysmex Recent Developments
Table 125. Apogee Flow Systems Basic Information
Table 126. Apogee Flow Systems HIV Diagnostics Product Overview
Table 127. Apogee Flow Systems HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Apogee Flow Systems Business Overview
Table 129. Apogee Flow Systems Recent Developments
Table 130. PointCare Technologies Inc. Basic Information
Table 131. PointCare Technologies Inc. HIV Diagnostics Product Overview
Table 132. PointCare Technologies Inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. PointCare Technologies Inc. Business Overview
Table 134. PointCare Technologies Inc. Recent Developments
Table 135. Zyomyx Inc. Basic Information
Table 136. Zyomyx Inc. HIV Diagnostics Product Overview
Table 137. Zyomyx Inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Zyomyx Inc. Business Overview
Table 139. Zyomyx Inc. Recent Developments
Table 140. Mylan inc. Basic Information
Table 141. Mylan inc. HIV Diagnostics Product Overview
Table 142. Mylan inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Mylan inc. Business Overview
Table 144. Mylan inc. Recent Developments
Table 145. Roche Diagnostics Basic Information
Table 146. Roche Diagnostics HIV Diagnostics Product Overview
Table 147. Roche Diagnostics HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Roche Diagnostics Business Overview
Table 149. Roche Diagnostics Recent Developments
Table 150. Siemens Healthcare Basic Information
Table 151. Siemens Healthcare HIV Diagnostics Product Overview
Table 152. Siemens Healthcare HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Siemens Healthcare Business Overview
Table 154. Siemens Healthcare Recent Developments
Table 155. Qiagen Basic Information
Table 156. Qiagen HIV Diagnostics Product Overview
Table 157. Qiagen HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Qiagen Business Overview
Table 159. Qiagen Recent Developments
Table 160. BioMerieux Basic Information
Table 161. BioMerieux HIV Diagnostics Product Overview
Table 162. BioMerieux HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. BioMerieux Business Overview
Table 164. BioMerieux Recent Developments
Table 165. Global HIV Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 166. Global HIV Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America HIV Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 168. North America HIV Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe HIV Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 170. Europe HIV Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific HIV Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 172. Asia Pacific HIV Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America HIV Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 174. South America HIV Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa HIV Diagnostics Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa HIV Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global HIV Diagnostics Sales Forecast by Type (2026-2035) & (K Units)
Table 178. Global HIV Diagnostics Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global HIV Diagnostics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 180. Global HIV Diagnostics Sales (K Units) Forecast by Application (2026-2035)
Table 181. Global HIV Diagnostics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of HIV Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global HIV Diagnostics Market Size (M USD), 2025-2035
Figure 5. Global HIV Diagnostics Market Size (M USD) (2020-2035)
Figure 6. Global HIV Diagnostics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. HIV Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global HIV Diagnostics Product Life Cycle
Figure 13. HIV Diagnostics Sales Share by Manufacturers in 2025
Figure 14. Global HIV Diagnostics Revenue Share by Manufacturers in 2025
Figure 15. HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market HIV Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by HIV Diagnostics Revenue in 2025
Figure 18. Industry Chain Map of HIV Diagnostics
Figure 19. Global HIV Diagnostics Market PEST Analysis
Figure 20. Global HIV Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global HIV Diagnostics Market Share by Type
Figure 27. Sales Market Share of HIV Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of HIV Diagnostics by Type in 2025
Figure 29. Market Share of HIV Diagnostics by Type (2020-2025)
Figure 30. Market Share of HIV Diagnostics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global HIV Diagnostics Market Share by Application
Figure 33. Global HIV Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global HIV Diagnostics Sales Market Share by Application in 2025
Figure 35. Global HIV Diagnostics Market Share by Application (2020-2025)
Figure 36. Global HIV Diagnostics Market Share by Application in 2025
Figure 37. Global HIV Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global HIV Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global HIV Diagnostics Market Size by Region (2020-2025)
Figure 40. North America HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America HIV Diagnostics Sales Market Share by Country in 2024
Figure 43. North America HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America HIV Diagnostics Market Size by Country in 2024
Figure 45. U.S. HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada HIV Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada HIV Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico HIV Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico HIV Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe HIV Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe HIV Diagnostics Market Size by Country in 2024
Figure 55. Germany HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific HIV Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific HIV Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific HIV Diagnostics Market Size by Region in 2024
Figure 68. China HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America HIV Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America HIV Diagnostics Sales Market Share by Country in 2024
Figure 80. South America HIV Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America HIV Diagnostics Market Size by Country in 2024
Figure 82. Brazil HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa HIV Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa HIV Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa HIV Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa HIV Diagnostics Market Size by Region in 2024
Figure 92. Saudi Arabia HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global HIV Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America HIV Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe HIV Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan HIV Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China HIV Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global HIV Diagnostics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global HIV Diagnostics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global HIV Diagnostics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global HIV Diagnostics Market Share Forecast by Type (2026-2035)
Figure 111. Global HIV Diagnostics Sales Forecast by Application (2026-2035)
Figure 112. Global HIV Diagnostics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of HIV Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global HIV Diagnostics Market Size (M USD), 2025-2035
Figure 5. Global HIV Diagnostics Market Size (M USD) (2020-2035)
Figure 6. Global HIV Diagnostics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. HIV Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global HIV Diagnostics Product Life Cycle
Figure 13. HIV Diagnostics Sales Share by Manufacturers in 2025
Figure 14. Global HIV Diagnostics Revenue Share by Manufacturers in 2025
Figure 15. HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market HIV Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by HIV Diagnostics Revenue in 2025
Figure 18. Industry Chain Map of HIV Diagnostics
Figure 19. Global HIV Diagnostics Market PEST Analysis
Figure 20. Global HIV Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global HIV Diagnostics Market Share by Type
Figure 27. Sales Market Share of HIV Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of HIV Diagnostics by Type in 2025
Figure 29. Market Share of HIV Diagnostics by Type (2020-2025)
Figure 30. Market Share of HIV Diagnostics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global HIV Diagnostics Market Share by Application
Figure 33. Global HIV Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global HIV Diagnostics Sales Market Share by Application in 2025
Figure 35. Global HIV Diagnostics Market Share by Application (2020-2025)
Figure 36. Global HIV Diagnostics Market Share by Application in 2025
Figure 37. Global HIV Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global HIV Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global HIV Diagnostics Market Size by Region (2020-2025)
Figure 40. North America HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America HIV Diagnostics Sales Market Share by Country in 2024
Figure 43. North America HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America HIV Diagnostics Market Size by Country in 2024
Figure 45. U.S. HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada HIV Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada HIV Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico HIV Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico HIV Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe HIV Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe HIV Diagnostics Market Size by Country in 2024
Figure 55. Germany HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific HIV Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific HIV Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific HIV Diagnostics Market Size by Region in 2024
Figure 68. China HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America HIV Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America HIV Diagnostics Sales Market Share by Country in 2024
Figure 80. South America HIV Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America HIV Diagnostics Market Size by Country in 2024
Figure 82. Brazil HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa HIV Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa HIV Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa HIV Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa HIV Diagnostics Market Size by Region in 2024
Figure 92. Saudi Arabia HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa HIV Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa HIV Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global HIV Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America HIV Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe HIV Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan HIV Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China HIV Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global HIV Diagnostics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global HIV Diagnostics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global HIV Diagnostics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global HIV Diagnostics Market Share Forecast by Type (2026-2035)
Figure 111. Global HIV Diagnostics Sales Forecast by Application (2026-2035)
Figure 112. Global HIV Diagnostics Market Share Forecast by Application (2026-2035)
